| Literature DB >> 35568886 |
Kai Xie1, Chao Zheng2, Gao-Ming Wang3, Yi-Fei Diao4, Chao Luo5, Ellen Wang6, Li-Wen Hu4, Zhi-Jian Ren7, Jing Luo8, Bin-Hui Ren9, Yi Shen10,11,12.
Abstract
BACKGROUNDS: High level of anion gap (AG) was associated with organic acidosis. This study aimed to explore the relationship between delta AG (ΔAG = AGmax - AGmin) during first 3 days after intensive care unit (ICU) admission and hospital mortality for patients admitted in the cardiothoracic surgery recovery unit (CSRU).Entities:
Keywords: Acid-basic disturbances; Anion gap; Cardiothoracic surgery; MIMIC III; Mortality
Mesh:
Year: 2022 PMID: 35568886 PMCID: PMC9107697 DOI: 10.1186/s12893-022-01625-9
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Fig. 1Selecting flow diagram
Reason for CSRU admission
| Reasons for admission | n (%) |
|---|---|
| Coronary artery disease, n (%) | 1005 (35.1) |
| Aortic valve disease, n (%) | 338(11.8) |
| Mitral valve disease, n (%) | 278 (9.7) |
| Chest pain, n (%) | 252 (8.8) |
| Aortic aneurysm, n (%) | 145 (5.1) |
| Infection or inflammation, n (%) | 83 (2.9) |
| Aortic dissection, n (%) | 80 (2.8) |
| Myocardial infarction, n (%) | 80 (2.8) |
| Congestive heart failure, n (%) | 76 (2.7) |
| Angina, n (%) | 73 (2.6) |
| Chest mass, n (%) | 53 (1.9) |
| Acute coronary syndrome, n (%) | 38 (1.3) |
| Dyspnea, n (%) | 32 (1.1) |
| Atrial fibrillation, n (%) | 29 (1.0) |
| Congenital heart disease, n (%) | 27 (0.9) |
| Other diseases, n (%) | 271 (9.5) |
Comparisons of characteristics between Survivors and Non–survivors
| Variable | Survivors (n = 2841) | Non–survivors (n = 19) | p value |
|---|---|---|---|
| Age (y) | 67.7 ± 12.1 | 81.2 ± 8.6 | < 0.001* |
| Male, n (%) | 1927 (67.8) | 7 (36.8) | 0.002* |
| White, n (%) | 2249 (79.2) | 12 (63.2) | 0.088 |
| Body mass index, Kg/m2 | 28.9 ± 6.0 | 28.8 ± 6.3 | 0.986 |
| Ventilation, n (%) | 2428 (85.5) | 11 (57.9) | 0.001* |
| SOFA | 5(3–7) | 6(4–8) | 0.109 |
| SAPS II | 36.8 ± 12.5 | 51.2 ± 13.5 | < 0.001* |
| SIRS | 2.8 ± 0.9 | 3.2 ± 0.9 | 0.077 |
| Comorbidities | |||
| COPD, n (%) | 20 (0.7) | 0 (0) | > 0.999 |
| Hypertension, n (%) | 1780 (62.7) | 6 (31.6) | 0.005* |
| Diabetes, n (%) | 910 (32.0) | 7 (36.8) | 0.654 |
| AG initial (mEq/L) | 11.3 ± 2.6 | 15.8 ± 4.1 | < 0.001* |
| AGmax (mEq/L) | 12.9 ± 3.3 | 21.9 ± 8.2 | < 0.001* |
| ΔAG (mEq/L) | 2 (1–5) | 7 (4–15) | < 0.001* |
| ΔNa + (mEq/L) | 7 (5–9) | 13 (5–20) | 0.012* |
| ΔCl − (mEq/L) | 4 (3–7) | 4 (0–9) | < 0.001* |
| ΔHCO3 − (mEq/L) | 7 (5–9) | 14 (7–19) | < 0.001* |
| Postoperative complications, n (%) | |||
| AKF | 381 (13.4) | 11 (57.9) | < 0.001* |
| Acidosis | 146 (5.1) | 4 (21.1) | 0.015* |
| Arrhythmia | 1175 (41.4) | 13 (68.4) | 0.017* |
| Acute respiratory failure | 151 (5.3) | 5 (26.3) | 0.003* |
| Pneumonia | 26 (0.9) | 2 (10.5) | 0.014* |
| Pulmonary embolism | 21 (0.7) | 0 (0.0) | > 0.999 |
| Laboratory indexes on POD1 | |||
| Serum creatinine (mg/dL) | 0.9 (0.8–1.2) | 1.5 (0.8–2.2) | 0.001* |
| Urea nitrogen (mg/dL) | 19 (14–26) | 38 (22–63) | < 0.001* |
| Glucose (mg/dL) | 127.6 ± 18.9 | 144.2 ± 51.8 | < 0.001* |
| pH | 7.40 ± 0.06 | 7.31 ± 0.13 | < 0.001* |
| Base excess (mEq/L) | 1 (0–3) | − 1 (− 9–1) | < 0.001* |
| Lactate (mmol/L) | 1.3 (1–1.6) | 1.7 (1.4–2.8) | 0.002* |
SOFA sequential organ failure assessment, SAPSII simplified acute physiology score II, SIRS systemic inflammatory response syndrome, AKF acute kidney failure, COPD chronic obstructive pulmonary disease, AG anion gap
Comparison of characteristics among patients with/without AG data
| Variables | Patients with AG (N = 2860) | Patients without AG (N = 4034) | p value |
|---|---|---|---|
| Age (y) | 67.9 ± 12.1 | 67.8 ± 12.0 | 0.734 |
| Male, n (%) | 1934 (67.6) | 2694 (66.8) | 0.464 |
| White, n (%) | 2261 (79.1) | 3184 (78.9) | 0.899 |
| Body mass index, Kg/m2 | 28.8 ± 6.0 | 28.7 ± 5.7 | 0.483 |
| SOFA | 5 (3–7) | 5 (3–6) | 0.128 |
| SAPSII | 36.9 ± 12.5 | 36.4 ± 11.7 | 0.089 |
| SIRS | 3 (2–4) | 3 (2–4) | 0.532 |
| Operation types, n (%) | |||
| CABG | 1283 (44.9) | 1816 (43.8) | 0.302 |
| Valve replacement or valvoplasty | 621 (21.8) | 958 (23.1) | |
| Resection of vessls | 232 (8.1) | 369 (8.9) | |
| Others | 724 (25.2) | 1004 (24.2) | |
| Postoperative complications, n (%) | |||
| AKF | 392 (13.7) | 544 (13.5) | 0.792 |
| Acidosis | 150 (5.2) | 206 (5.1) | 0.798 |
| Arrhythmia | 1188 (41.5) | 1692 (41.9) | 0.737 |
| Acute respiratory failure | 156 (5.5) | 230 (5.7) | 0.660 |
| Pneumonia | 28 (1.0) | 48 (1.2) | 0.409 |
| Pulmonary embolism | 20 (0.7) | 36 (0.9) | 0.379 |
| Hospital mortality | 19 (0.7) | 35 (0.9) | 0.295 |
| ICU LOS, median (IQR), day | 2.1 (1.3–3.4) | 2.3 (1.3–3.6) | 0.122 |
| Hospital LOS, median (IQR), day | 7.6 (5.8–11.3) | 7.9 (5.9–11.5) | 0.145 |
SOFA sequential organ failure assessment, SAPSII simplified acute physiology score II, SIRS systemic inflammatory response syndrome, CABG coronary artery bypass graft, AKF acute kidney failure, ICU intensive care unit, LOS length of stay, IQR interquartile ranges
Fig. 2The crude association between ΔAG and hospital mortality using Lowess smoothing technique
Univariate and multivariate analysis for ΔAG predicting hospital mortality
| Variables | Odds ratios | β | 95% confidence interval | p value |
|---|---|---|---|---|
| Univariate logistic regression | ||||
| ΔAG (≥ 7 vs < 7) | 9.54 | 2.26 | 3.81–23.87 | < 0.001 |
| ΔAG, continuous | 1.24 | 0.21 | 1.16–1.32 | < 0.001 |
| Gender (male vs female) | 0.28 | − 1.28 | 0.11–0.70 | 0.007 |
| Race (white vs non-white) | 2.21 | 0.80 | 0.87–5.65 | 0.096 |
| Age | 1.15 | 0.14 | 1.08–1.22 | < 0.001 |
| Body mass index | 0.99 | 0.00 | 0.93–1.08 | 0.986 |
| Serum Creatinine | 1.34 | 0.29 | 1.12–1.61 | 0.002 |
| Urea nitrogen | 1.04 | 0.04 | 1.03–1.06 | < 0.001 |
| Lactate | 1.87 | 0.62 | 1.55–2.24 | < 0.001 |
| Base excess | 0.75 | − 0.28 | 0.70–0.82 | < 0.001 |
| White blood cell | 1.06 | 0.05 | 0.99–1.12 | 0.108 |
| AKF | 8.87 | 2.18 | 3.55–22.21 | < 0.001 |
| Acidosis | 4.92 | 1.59 | 1.63–15.01 | 0.005 |
| Diabetes | 1.24 | 0.21 | 0.49–3.15 | 0.655 |
| SAPSII | 1.07 | 0.07 | 1.04–1.10 | < 0.001 |
| SOFA | 1.17 | 0.15 | 1.01–1.35 | 0.040 |
| SIRS | 1.66 | 0.51 | 0.94–2.93 | 0.080 |
| Multivariate logistic regression | ||||
| ΔAG, continuous | 1.24 | 0.21 | 1.11–1.39 | < 0.001 |
| Age | 1.14 | 0.13 | 1.07–1.21 | < 0.001 |
| Base excess | 0.81 | − 0.21 | 0.72–0.90 | < 0.001 |
| AKF | 14.87 | 2.69 | 2.81–77.55 | 0.001 |
| ΔAG × AKF | 0.84 | − 0.18 | 0.70–1.01 | 0.051 |
| Constant | − 15.69 | − 20.98 to − 10.40 | < 0.001 | |
| ΔAG (≥ 7 vs < 7) | 4.23 | 1.44 | 1.22–14.63 | 0.023 |
| Age | 1.14 | 0.13 | 1.07–1.21 | < 0.001 |
| Base excess | 0.78 | − 0.25 | 0.70–0.86 | < 0.001 |
| AKF | 7.81 | 2.06 | 1.59–38.47 | 0.011 |
| ΔAG × AKF | 0.90 | − 0.10 | 0.75–1.09 | 0.278 |
The mean VIF of model 1 was 2.78
AG anion gap, AKF acute kidney failure, SAPSII simplified acute physiology score II, SOFA sequential organ failure assessment, SIRS systemic inflammatory response syndrome
Fig. 3ROC curves of acid–base variables in predicting hospital mortality
Fig. 4Kaplan Meier curve of 90-day OS stratified by ΔAG ≥ 7 and ΔAG < 7